Morgan Stanley Private Equity Asia provided Fullife Healthcare with $22 million in Series C funding (MSPEA). Fullife Healthcare is a pioneer in the development of effervescent technology for healthcare and nutraceutical products. The company's flagship brands are Fast&Up and Chicnutrix.
"Our focus has always been to bring forth high-quality nutrition to India, ensuring that Indians
get the best-in-class supplements to keep them active and feeling good," said Varun Khanna, CEO of Fullife Healthcare. Indians are becoming moreaware and actively seeking genuine, high-quality products that meet their daily needs to be healthy, active, and attractive."
This round of funding will help Fast&Up and Chicnutrix expand their domestic presence, improve their manufacturing capabilities, and accelerate their global momentum.
"Chicnutrix was founded to become every woman's Nutrition BFF for their beauty and wellness needs," said Shilpa Khanna Thakkar, CEO of Chicnutrix. Morgan Stanley's investment confirms that we are on the right track. This is a tremendous opportunity for Chicnutrix, coming at a time when we are looking to strengthen ourselves and accelerate our vision of becoming a global brand."
She went on to say that India has been undergoing a tremendous revolution in recent years, which the pandemic has accelerated, and that there is now a holistic approach to wellness and beauty.